Skip to content

Management of Migraine By Netikarma End Nasya

A Combined Study Of Girikarni Phaladi Nasya And Neti Karma In Management Of Ardhavabhedhaka (Migraine)

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050841
Enrollment
40
Registered
2023-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G900- Idiopathic peripheral autonomic neuropathy

Interventions

Intervention1: Girikarniphaladi Nasya and jal Netikarma in migraine( Ardhavabhedaka).: In single group Girikarniphaladi Nasyakarma - 2 drops(1ml) in each nostril and Netikarma with luke warm water(

Sponsors

UPGIASR Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor
Dr Neha verma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 19 to 40 years. 2.Patients presenting with signs and symptoms of Ardhavabhedaka, described as per Ayurvedic and morden science.

Exclusion criteria

Exclusion criteria: 1 Patients Below age 19 years above 40years 2 Pregment and Lactating woman. 3 Patients suffering from major disease e.g.tuberculosis,cancer,diabetes mallities,heart disease, hypertension etc. 4 Ophthalmology migraine 5 Complicated migraine 6 Secondary headache caused by meningitis,tumor, encephalitis,cervical spondylitis, Refractive error and increase intra ocular pressure 7 Patients using any systemic drugs.

Design outcomes

Primary

MeasureTime frame
To Study the Effect of Girikarni Phaladi Nasya(nasal oleation and Netikarma(nasal Irrigation)Timepoint: 90 days

Secondary

MeasureTime frame
To relief in symptoms of Ardhavabhedaka (migraine) by above Ayurveda ProcedureTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Neha Verma

University Post Graduate Institute of Ayurved Studies And Research

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026